EP 050 Industry Insights - AI in Longevity Research

EPISODE 050: "AI in Longevity Research" ARTIFICIAL INTELLIGENCE | Longevity Science | Anti-Aging Medicine | Pharmaceutical Manufacturing | Healthspan Extension Discover how artificial intelligence is revolutionizing longevity research and creating unprecedented demand for pharmaceutical manufacturing capacity. This episode explores the convergence of AI and aging science—from drug discovery that's 70% successful (compared to single-digit success rates in traditional methods) to the first FDA-approved dog longevity trials paving the way for human therapies. Learn why extending healthy human lifespan by just one year could add $38 trillion to the global economy. KEY TOPICS COVERED: The Science of Aging The 12 hallmarks of aging: cellular senescence, mitochondrial dysfunction, telomere shortening Lifespan vs healthspan: adding life to years, not just years to life Biological age vs chronological age measured with AI-powered aging clocks Polypharmacology: targeting multiple aging pathways simultaneously Loyal's STAY study with 1,300+ dogs testing longevity drugs IGF-1 targeting for metabolic aging in large breeds AI & Machine Learning Breakthroughs Multi-omics analysis integrating genomics, proteomics, microbiome, and metabolome data Generative AI designing novel molecules in 46 days (Insilico Medicine) 70% success rate in AI-identified anti-aging compounds (Scripps Research, May 2025) In-silico modeling and digital twins for virtual clinical trials Drug repurposing: discovering hidden longevity benefits in existing medications Current Clinical Breakthroughs GLP-1 revolution: Ozempic, Wegovy, Mounjaro showing unexpected longevity benefits Metformin and rapamycin in clinical trials as anti-aging drugs Cellular reprogramming: reversing biological age at the cellular level NAD+ boosters and senolytic drugs clearing zombie cells FDA approval pathway for dog longevity drugs (LOY-002) INS018_055: AI-designed drug showing activity against six aging mechanisms Manufacturing Revolution & Scalability Cloud-based Manufacturing Execution Systems (MES) for unprecedented demand Lessons from Ozempic shortage and the coming longevity surge Real-time orchestration for complex biologics, cell therapies, gene therapies AI-powered production optimization and predictive bottleneck prevention Digital twin manufacturing simulations Connected manufacturing networks across global facilities Economic & Societal Impact Projected longevity drug market: $75-140 billion by 2030 Novo Nordisk's $16.5B Catalent acquisition; Eli Lilly's $50B+ capacity investment "Longevity as a Service" subscription models Restructuring society: multiple careers, extended productivity Democratizing access to longevity treatments globally Future Predictions First wave of AI-designed longevity drugs (2025-2027) 100x demand increase for longevity pharmaceuticals Cellular reprogramming clinics for biological age reversal Maximum human healthspan potentially reaching 120+ years 3D-printed organs and on-demand replacement parts Perfect for: Pharmaceutical manufacturing professionals Biotechnology researchers and scientists Contract Manufacturing Organization (CMO) executives Healthcare innovation and longevity enthusiasts Quality assurance and regulatory specialists Manufacturing operations leaders Featured Companies & Technologies: Loyal (STAY Study) | Insilico Medicine | Novo Nordisk | Eli Lilly | Catalent | IIT-Delhi AgeXtend | Apprentice.io Tempo MES Host: Frank Maggiore Series: Apprentice.io Industry Insights Podcast #longevity #AIinMedicine #AntiAging #Pharmaceutical #Biotechnology #Manufacturing #Healthspan #DrugDiscovery #PrecisionMedicine #CloudMES #BiologicalAge #GLP1 #CellularReprogramming #Bioreactors #PharmaceuticalManufacturing #MES #HealthTech #AgingResearch #BioManufacturing #DigitalTransformation ENGAGE WITH US: Like, comment with your thoughts on longevity medicine Subscribe for weekly science-based pharmaceutical insights Share with colleagues in pharma and biotech Learn more: apprentice.io Disclaimer: The content in this video podcast is for informational purposes only. The views and opinions expressed are those of the speakers and do not necessarily reflect the official policy or position of Apprentice.io or any other agency, organization, employer or company. This podcast does not constitute medical, financial, regulatory, or legal advice. Viewers should consult with appropriate professionals for specific advice. Apprentice.io makes no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability of the information contained in this video. Any reliance you place on such information is strictly at your own risk. Related Topics: drug repurposing, metformin longevity, rapamycin, senolytics, biopharmaceutical manufacturing, fermentation technology, CMO partnerships, GMP compliance, bioprocess engineering